UPDATE 4/29/2020 – COVID-19: Keeping Up With A Moving Target

Dr. Auwaerter updates us on COVID-19 and answers your questions. Topics covered:

  • Infection Rates – New York vs. Los Angeles
  • Remdesivir trial breaking news
  • COVID-19 transmission data
  • Serology testing: Reliable?
  • Children and COVID-19, and more

UPDATE 4/24/2020 – COVID-19: Keeping Up With A Moving Target

In this new series, Sue Hansen, MSN, RN from UW Medicine at Harborview Medical Center in Seattle provides weekly updates for clinicians caring for patients with COVID-19. She shares practical information for treating COVID-19 patients in the ICU and other settings, and offers recommended best practices. In this episode, she discusses proning:

  • Why we prone, physiological benefits
  • When to and not to prone
  • Complications
  • Special COVID-19 considerations, and more

UPDATE 4/22/2020 – COVID-19: Keeping Up With A Moving Target

Dr. Auwaerter updates us on COVID-19 and answers your questions. Topics covered:

  • LA County antibody testing
  • Treatment guidelines from the National Institute of Health
  • NEJM study on two New York City hospitals
  • Data about use of medications for hypertension
  • Update on using plasma to treat patients
  • Reliability of IgM/IgG testing kits
  • And more

Hepatitis C Treatment in the HIV Coinfected and Dialysis Populations

Volume 4, Issue 7.

Drs Paul Martin, MD and Kalyan Ram Bhamidimarri, MD cover the important topic of Hepatitis C Treatment in the HIV Coinfected and Dialysis Populations in the format of case-study scenarios for the clinical practice.

Highlights from the 2014 EASL Meeting

Volume 3, Issue 12.

Mark S. Sulkowski, MD, Professor of Medicine, Medical Director, Viral Hepatitis Center in the Divisions of Infectious Diseases and Gastroenterology/Hepatology at the Johns Hopkins University School of Medicine, Raymond T. Chung, Associate Professor of Medicine, Harvard Medical School, Director of Hepatology, Vice Chief of Gastroenterology at Massachusetts General Hospital, and Laurent Castera, MD, PhD, Department of Hepatology, Beaujon Hospital, AP-AP, INSERM U773 at the University of Paris-Diderot. Discuss new information presented at the 2014 European Association for the Study of the Liver (EASL) meeting, as well as non-invasive markers of liver disease.